ADMA BIOLOGICS, INC. Proceeds from Notes Payable
ADMA BIOLOGICS, INC. (ADMA) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-02-25
- ADMA BIOLOGICS, INC. proceeds from notes payable for the quarter ending 2023-12-31 was $135.00M.
- ADMA BIOLOGICS, INC. proceeds from notes payable for the quarter ending 2023-09-30 was $0.00.
- ADMA BIOLOGICS, INC. proceeds from notes payable for the quarter ending 2023-06-30 was $0.00.
- ADMA BIOLOGICS, INC. proceeds from notes payable for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. proceeds from notes payable for fiscal 2025 was $0.00.
- ADMA BIOLOGICS, INC. proceeds from notes payable for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ADMA BIOLOGICS, INC. proceeds from notes payable for fiscal 2023 was $135.00M, a 11.04% decline from fiscal 2022.
- ADMA BIOLOGICS, INC. proceeds from notes payable for fiscal 2022 was $151.75M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $135.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $135.00M derived: sum of 2 quarters · filed 2026-02-25 | $135.00M derived: sum of 3 quarters · filed 2026-02-25 | $135.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $151.75M 10-K · filed 2025-03-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $151.75M 10-Q · filed 2023-11-08 | $151.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $151.75M 10-Q · filed 2023-08-09 | $151.75M derived: sum of 3 quarters · filed 2024-02-28 | $151.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $151.75M 10-Q · filed 2023-05-10 | $151.75M derived: sum of 2 quarters · filed 2024-02-28 | $151.75M derived: sum of 3 quarters · filed 2024-02-28 | $151.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $15.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $15.00M derived: sum of 3 quarters · filed 2022-08-10 | $15.00M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | $15.00M derived: sum of 2 quarters · filed 2022-05-11 | $15.00M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $15.00M derived: sum of 2 quarters · filed 2022-03-24 | $27.50M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $12.50M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $12.50M 10-Q · filed 2021-08-11 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $0.00 derived: sum of 2 quarters · filed 2016-03-23 | $0.00 derived: sum of 3 quarters · filed 2016-03-23 | $0.00 10-K · filed 2016-03-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-11-10 | $0.00 10-Q · filed 2015-11-10 | $5.00M derived: sum of 4 quarters · filed 2016-03-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $0.00 10-Q · filed 2015-08-11 | $5.00M derived: sum of 3 quarters · filed 2016-03-23 | $5.00M derived: sum of 4 quarters · filed 2016-03-23 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 | $5.00M derived: sum of 2 quarters · filed 2016-03-23 | $5.00M derived: sum of 3 quarters · filed 2016-03-23 | $5.00M derived: sum of 4 quarters · filed 2016-03-23 |
| 2014-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $5.00M derived: sum of 2 quarters · filed 2016-03-23 | $5.00M derived: sum of 3 quarters · filed 2016-03-23 | $9.85M 10-K · filed 2016-03-23 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-11-10 | $4.85M 10-Q · filed 2015-11-10 | $4.85M derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $4.85M 10-Q · filed 2015-08-11 | $4.85M derived: sum of 3 quarters · filed 2015-08-11 | $4.85M derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | $4.85M 10-Q · filed 2015-05-12 | $4.85M derived: sum of 2 quarters · filed 2015-05-12 | $4.85M derived: sum of 3 quarters · filed 2015-05-12 | $4.85M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $0.00 derived: sum of 2 quarters · filed 2015-03-09 | $0.00 derived: sum of 3 quarters · filed 2015-03-09 | $1.00M 10-K · filed 2015-03-09 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $1.00M 10-Q · filed 2014-11-10 | $4.91M derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.00M 10-Q · filed 2014-08-11 | $4.91M derived: sum of 3 quarters · filed 2014-08-11 | |
| 2013-03-31 | $1.00M 10-Q · filed 2014-05-12 | $4.91M derived: sum of 2 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.91M 10-K · filed 2014-03-28 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | -$1.20M derived: sum of 2 quarters · filed 2013-05-14 | -$850.00K derived: sum of 3 quarters · filed 2013-05-14 | -$300.00K derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | -$850.00K derived: sum of 2 quarters · filed 2013-03-06 | -$300.00K derived: sum of 3 quarters · filed 2013-03-06 | $0.00 10-K · filed 2013-03-06 |
| 2011-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $900.00K derived: sum of 2 quarters · filed 2012-11-13 | $1.20M 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $850.00K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $300.00K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |